학술논문
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer
Document Type
Journal
Author
Jenkins, Kurt A.; Park, Miso; Pederzoli-Ribeil, Magali; Eskiocak, Ugur; Johnson, Parker; Guzman, Wilson; Mclaughlin, Megan; Moore-Lai, Deborah; O'Toole, Caitlin; Liu, Zhen; Nicholson, Benjamin; Flesch, Veronica; Qiu, Huawei; Clackson, Tim; O'Hagan, Ronan C.; Rodeck, Ulrich; Karow, Margaret; O'Neil, Jennifer; Williams, John C.
Source
Subject
Language
English
ISSN
20511426